Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
about
Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.The nine-year changes of the incidence and characteristics of metabolic syndrome in China: longitudinal comparisons of the two cross-sectional surveys in a newly formed urban community.Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery diseaseThe triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia.Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease.
P2860
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
@ast
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
@en
type
label
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
@ast
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
@en
prefLabel
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
@ast
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
@en
P2093
P2860
P1476
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
@en
P2093
Jianhua Zhang
Tingting Du
Xingxing Sun
Xuefeng Yu
P2860
P2888
P356
10.1186/S12933-015-0306-0
P407
P577
2015-10-29T00:00:00Z
P6179
1035984559